Skip to main content
. 2023 Nov 17;10(12):ofad579. doi: 10.1093/ofid/ofad579

Table 1.

Characteristics of Active Duty US Military Health System Beneficiaries who Responded to ≥1 EPICC Survey With Fitness Questions

SARS-CoV-2-(n = 1591), No. (%) SARS-CoV-2+ (n = 1923), No. (%) Total (n = 3514), No. (%) P Value
Age group .04a
 18–29 y 559 (35.1) 598 (31.1) 1157 (32.9)
 30–39 y 646 (40.6) 828 (43.1) 1474 (41.9)
 40+ y 386 (24.3) 497 (25.8) 883 (25.1)
Female 451 (28.3) 552 (28.7) 1003 (28.5) .81a
Race/ethnicity .17a
 Asian 88 (5.5) 87 (4.5) 175 (5.0)
 Black 125 (7.9) 134 (7.0) 259 (7.4)
 Hispanic or Latino 224 (14.1) 311 (16.2) 535 (15.2)
 Other 173 (10.9) 187 (9.7) 360 (10.2)
 White 981 (61.7) 1204 (62.6) 2185 (62.2)
Service branch .02a
 Air Force 301 (18.9) 363 (18.9) 664 (18.9)
 Army 549 (34.5) 728 (37.9) 1277 (36.3)
 Marines 83 (5.2) 116 (6.0) 199 (5.7)
 Navy 318 (20.0) 386 (20.1) 704 (20.0)
 Other 340 (21.4) 330 (17.2) 670 (19.1)
BMI category <.01a
 Under/normal weight (BMI <25 kg/m2) 418 (26.3) 444 (23.1) 862 (24.5)
 Overweight (BMI 25–29 kg/m2) 825 (51.9) 947 (49.2) 1772 (50.4)
 Obese (BMI 30–34 kg/m2) 289 (18.2) 426 (22.2) 715 (20.3)
 Severely obese (BMI ≥35 kg/m2) 59 (3.7) 106 (5.5) 165 (4.7)
Charlson comorbidity index category .74a
 0 1453 (91.3) 1758 (91.4) 3211 (91.4)
 1–2 129 (8.1) 151 (7.9) 280 (8.0)
 3–4 4 (0.3) 9 (0.5) 13 (0.4)
 5+ 5 (0.3) 5 (0.3) 10 (0.3)
Outpatient 1589 (99.9) 1872 (97.3) 3461 (98.5) <.01a
Maximum days from first SARS-CoV-2 positive to survey
 Median (Q1, Q3) NA 276.0 (136.0, 354.0) 276.0 (136.0, 354.0)
 Min–max NA 15.0–404.0 15.0–404.0
Vaccination status at time of SARS-CoV-2 infection
 Unvaccinated NA 721 (37.5) 721 (37.5)
 Fully vaccinated NA 727 (37.8) 727 (37.8)
 Boosted NA 475 (24.7) 475 (24.7)
Infected or enrolled during different variant periods <.01a
 Pre-Delta (2/28/20–6/14/21) 665 (41.8) 645 (33.5) 1310 (37.3)
 Delta (6/15/21–12/31/21) 734 (46.1) 425 (22.1) 1159 (33.0)
 Omicron (1/1/22+) 192 (12.1) 853 (44.4) 1045 (0.7)

Abbreviations: BMI, body mass index; EPICC, Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

aPearson chi-square test.